Your support will help find treatments

Jason Powell is a senior researcher at the Centre for Cancer Biology – a world-class research centre and foundation partner with the Royal Adelaide Hospital. Jason and his team are on the verge of developing a drug that may be able to halt and reverse many-sub types of Acute Myeloid Leukaemia (AML) – and prevent their return after remission. Jason and his team have identified a protein that is hyper-activated in AML. The research team is now focused on developing new drugs to target this protein. Initial experimentation shows that these drugs can selectively target the leukemic cells and unlike standard chemotherapies, have no detrimental side effects on normal cell function.

The early signs are there that it could become one of the world’s first targeted treatments for AML.

Can you imagine discovering a cure for AML?

With your support, we can make this is a reality.